Clinical Trials Logo

Adolescent Suicide clinical trials

View clinical trials related to Adolescent Suicide.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04613453 Recruiting - Clinical trials for Adolescent Depression

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

Start date: January 21, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if intravenous ketamine reduces suicidal thinking compared to an active placebo (midazolam) in adolescents who have treatment resistant depression and a recent history of a suicide event (defined as a suicide attempt, emergency room evaluation for suicidal thinking, or a transition to inpatient care for suicidality in the past 120 days). The primary objective of this study is to determine whether ketamine reduces suicidal ideation (as measured via the C-SSRS, recent ideation scale) relative to an active control, midazolam, 48-hours after first administration in adolescents with TRD at high suicide risk.